Braid-Forbes MJ, Forbes KF, Ziskind M; AcademyHealth. Meeting (2005 : Boston, Mass.).
Abstr AcademyHealth Meet. 2005; 22: abstract no. 3646.
The Moran Company, , 1655 N. Fort Myer Dr Suite 1250, Arlington, VA 22209 Tel. (703)841-8402 Fax
RESEARCH OBJECTIVE: To measure the effect of reductions in payments for pharmaceuticals in the hospital outpatient setting on the number of hospitals offering therapies and the level of utilization. STUDY DESIGN: Using Medicare claims data for three years, we constructed a longitudinal database of quarterly utilization and hospital participation for over 100 separately paid pharmaceuticals. We combined this with data on the actual acquisition cost of the drugs and Medicare payment rates. The effect by hospital ownership type was also studied. The number of hospitals and number of administrations were regressed on a number of binary variables. POPULATION STUDIED: Medicare PRINCIPAL FINDINGS: Changes in payment rate had an adverse impact on the number of administrations for a number of drugs. Further analysis to be conducted. CONCLUSIONS: IMPLICATIONS FOR POLICY, DELIVERY OR PRACTICE: Payment rates for separately paid pharmaceuticals that are below acquisition cost may have an adverse impact on access.
Publication Types:
Keywords:
- Health Expenditures
- Hospitals
- Medicare
- Outpatients
- economics
- instrumentation
- utilization
- hsrmtgs
UI: 103623109
From Meeting Abstracts